Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

586 articles

Research Review

Showing 1–3 of 3 articles · Keyword: Theranostics Clear keyword

International journal of pharmaceutics2026ReviewNon-viral Gene DeliveryDrug Delivery

1. Biogenic gold nanoparticles in breast cancer nanomedicine: sustainable synthesis, multifunctional engineering, and the road to clinical translation

Singh Ur, Mishra G, Leharwani M, Abourehab Mas, Gupta G, Wen Goh K, Et Al.

The use of plant, algal, microbial or biomolecule based reducing and capping agents to synthesize gold nanoparticles (AuNPs) has paved the way for the use of these materials as versatile candidates for breast-cancer nanomedicine. In addition to being a more sustainable synthetic pathway, the biological elements…

Read the article

Frontiers in drug delivery2026ReviewDrug Delivery

2. Metal-organic and covalent organic frameworks for precision drug delivery: a precision-by-design evidence framework for biologically accountable nanomedicine

Li X, Zhang H, Ding R, Wang F

Metal-organic frameworks and covalent organic frameworks offer a rare opportunity to design drug carriers from molecular building blocks upward. Yet high loading capacity and stimulus-responsive release alone do not constitute precision delivery. We critically synthesized evidence on MOF and COF pore-level cargo…

Read the article

Frontiers in oncology2026ReviewDrug Delivery

3. Extracellular vesicles as biomimetic platforms for photo-assisted cancer therapy: evolution from synthetic nanocarriers to engineered therapeutic systems

Beaugé L, Ibarra Le

Photo-assisted therapies have emerged as promising strategies for cancer treatment by combining localized tumor ablation with the induction of systemic antitumor immune responses. Despite encouraging preclinical and clinical advances, their therapeutic efficacy remains limited by the unfavorable pharmacokinetics…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.